hypothyroidism glp-1 Why Women with Hashimoto's Are Turning to Semaglutide and Tirzepatide for Weight Loss and Wellness: Envizion Medical: Wellness Center 10 Surprising Facts About GLP-1/GIP
Description
Patients enrolled in phase III clinical trials have completed open-label extensions of up to 3.5 years
Ther Adv Drug Saf 2020;11:2042098620938595
Yet subsequent large-scale trials such as REWIND (dulaglutide) and LEADER (liraglutide) did not replicate this signal
Providers at Synchronicity Health carefully review each patients medical history and lifestyle before creating a customized treatment plan
The resulting cohort consisted of 1,884 members with 1 Wegovy only claim, 384 with 1 Saxenda only claim, and 281 with 1 claim of each medication
10.1097/prs.0000000000007636 60 JohnsonA
